The Heterogeneity, Therapeutic Advancements, and Updated Guidelines for the Treatment of RRMM
The Heterogeneity, Therapeutic Advancements, and Updated Guidelines for the Treatment of RRMM is organized by Healthcare Made Practical (HMP) Global.
Release Date: June 20, 2023
Expiration Date: June 20, 2024.
Description:
This on-demand webcast is available with synchronized slides and video/audio. If you claimed credit for the live program held on June 4, 2023 in Chicago, Illinois, you are not eligible to claim credit for this enduring activity.
To be eligible for credit, participants must complete the educational activity and complete the activity evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Learning Objectives:
After participating in this activity, learners should be better able to:
• Evaluate the most recent clinical efficacy and safety data surrounding new and emerging therapeutics to develop treatment algorithms for patients with RRMM
• Implement alternative treatment approaches and SOC according to current guideline recommendations in patients that continue to experience RRMM after multiple therapeutic attempts
• Discuss mechanisms of action (MOAs), adverse events (AEs), and associated toxicities observed with novel and emerging therapies for RRMM
• Assess barriers to optimal treatment and management of patients with RRMM
• Describe advances in implementation of current and emerging antibody therapy strategies, protocols, and clinical pathways in the treatment and management of patients with RRMM.
Additional details will be posted as soon as information is available.